Skip to main content

AVIVA PLC

Position in KROS — Keros Therapeutics, Inc.

CIK 1140022 LONDON, X0

Position in KROS

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$378,749
New position
Shares Held
34,307
first reported quarter
Ownership
0.173%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AVIVA PLC holds $285,082,134 across 22 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in KROS

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-03-31 $378,749 34,307